ELORAC
Elorac, Inc. is a privately owned, specialty pharmaceutical company engaged in the development and commercialization of novel products for dermatology, allergy and oncology. The Company markets dermatological products in the United States through its dedicated internal sales force. In addition to the newly acquired Heprotect compounds, Elorac’s development pipeline includes: naloxone lotion for treatment of pruritus accompanying cutaneous T-cell lymphoma, a product with orphan drug and fast-track designations from the U.S. Food and Drug Administration; cidoxepin, a highly potent histamine H1-receptor antagonist being developed for relief of chronic urticaria; and a once-weekly tablet for nodulocystic acne.
ELORAC
Social Links:
Industry:
Biopharma Pharmaceutical
Founded:
2009-01-01
Address:
Vernon Hills, Illinois, United States
Country:
United States
Website Url:
http://www.eloracpharma.com
Total Employee:
11+
Status:
Active
Contact:
(847)362-8200
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
Dyax
Dyax Corp. (Dyax) is a biopharmaceutical company focused on the discovery, development and commercialization of biotherapeutics for unmet
Fedora Pharmaceuticals
Fedora Pharmaceuticals engages in the discovery and development of antibiotics for life-threatening microbial drug resistance needs.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-04-15 | Gideon Pharmaceuticals | Gideon Pharmaceuticals acquired by Elorac | N/A |
Official Site Inspections
http://www.eloracpharma.com
- Host name: 204.238.174.34.bc.googleusercontent.com
- IP address: 34.174.238.204
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
